Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Paolini John F. exercised options for 8,328 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Paolini John F. (CHIEF MEDICAL OFFICER) exercised options for 8,328 Kiniksa Pharmaceuticals International, Plc shares, leaving 69,922 shares. Filed Sep 3, 2026 (Form 4).

Options exercised
8,328 shares
Holding after
69,922 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Class A Ordinary ShareOption exercise2,49768,120Direct
Sep 1, 2026Class A Ordinary ShareOption exercise1,62469,744Direct
Sep 1, 2026Class A Ordinary ShareOption exercise1,75071,494Direct
Sep 1, 2026Class A Ordinary ShareOption exercise2,45773,951Direct
Sep 1, 2026Class A Ordinary ShareShares withheld for tax4,029US$79.2869,922Direct

Source

View original at SEC

Related